Ventana medical systems INC.: maintenance of benchmark XT; serial # 711798

Ended Purchase Order Awarded Last action

Contract number
HHSN261201400273P
Awardee
Awarding agency
Obligated
$45,819

Award facts

Opportunity
  • 2252014 Solicitation number
Contract value 100% obligated
$45,818.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 · DE-obligation of funds from FY2014 expiring lines -$6,546
Other Administrative Action 1 $0
Original award $52,364

About this award

The National Cancer Institute awarded a purchase order to Roche Diagnostics Corporation for maintenance of a Benchmark XT histology staining platform (Serial #711798) with a ceiling value of $45,818.50 and an award date of April 24, 2014. Place of performance is Bethesda, Maryland. The order represents a de-obligation of funds from expiring FY2014 lines, with an ultimate completion date of April 23, 2015. Pricing is firm fixed price.

Quick answers

Who was awarded contract HHSN261201400273P?

HHSN261201400273P was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on April 24, 2014.

How much is contract HHSN261201400273P worth?

The government has obligated $45,819 on HHSN261201400273P.

Was contract HHSN261201400273P competed?

The extent of competition for HHSN261201400273P was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award